GlassScriptPhysician profile
Melissa J Hague
NPI 1467462812
$3,516.62
in general payments reported to CMS, 2019-2025
28 companies · $524 in 2025
The $524 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $286 · 2021: $442 · 2022: $643 · 2023: $583 · 2024: $608 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,714.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $673.54 | 2019-2023 | |
| Hologic Sales and Service, LLC | $439.36 | 2021-2025 | Novasure, Thinprep 2000 Processor, Aptima |
| Astellas Pharma US INC | $350.91 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $293.44 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $245.11 | 2023-2025 | Myfembree |
| Medtronic, INC. | $232.72 | 2021-2025 | Truclear, V-Loc 180 |
| Myovant Sciences INC. | $199.07 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $114.68 | 2019-2023 | |
| Biogen, INC. | $104.59 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $81.56 | 2021-2025 | Slynd |
| Amag Pharmaceuticals, INC. | $77.86 | 2019 | |
| Intuitive Surgical, INC. | $75.51 | 2020 | |
| Allergan, INC. | $72.86 | 2019-2020 | |
| Novo Nordisk INC | $63.51 | 2022-2024 | |
| Conmed Corporation | $62.50 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Momentis Surgical INC. | $60.00 | 2022 | |
| Dexcom, INC. | $57.88 | 2025 | Dexcom G6 Transmitter |
| Agile Therapeutics, INC. | $54.16 | 2023 | Twirla |
| Sage Therapeutics, LLC | $40.12 | 2022 | |
| Coopersurgical, INC. | $38.91 | 2021-2022 | |
| Minerva Surgical, INC | $36.74 | 2022-2023 | |
| Shield Therapeutics INC | $32.86 | 2025 | |
| Duchesnay USA Incorporated | $26.24 | 2019 | |
| Baxter Healthcare | $21.59 | 2023 | Perclot |
| Mayne Pharma Commercial LLC | $16.33 | 2022 | |
| Smith+Nephew, INC. | $15.78 | 2025 | Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Urovant Sciences INC | $15.11 | 2021 | |
| Therapeuticsmd, INC. | $13.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Hague listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.